CMV p65 antibody

Catalog No. ABIN6941378

Product Details anti-CMV p65 Antibody

Target: CMV p65 (Cytomegalovirus p65 (CMV p65))

Reactivity: Human Herpesvirus 5 (HHV-5)

Host: Mouse

Clonality: Monoclonal

Conjugate: This CMV p65 antibody is un-conjugated

Application: ELISA, Immunofluorescence (IF), Coating (Coat), Immunocytochemistry (ICC)

Purification: Purified by Protein A/G

Immunogen: Recombinant CMV-p65 protein

Clone: CMV101

Isotype: IgG1 kappa

Application Details

Application Notes:

Positive Control: CMV-infected cells. Tissues.

Known Application: ELISA (For coating, order Ab without BSA), Immunocytochemistry (Acetone or paraformaldehyde fixed) (0.5-1 μg/mL for 30 min), Immunofluorescence (0.5-1 μg/mL), Optimal dilution for a specific application should be determined.

Restrictions: For Research Use only

Handling

Concentration: 200 μg/mL

Buffer: 10 mM PBS with 0.05 % BSA & 0.05 % azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Expiry Date: 24 months

Target Details for CMV p65

Target: CMV p65 (Cytomegalovirus p65 (CMV p65))

Alternative Name: Cytomegalovirus p65 (CMV-p65) (CMV p65 Products)

Target Type: Viral Protein

Background: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Molecular Weight: 65kDa